Delivery Order SPE2DB24D2205-SPE2DB25FEEYB
Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $18,614.28 firm-fixed-price delivery order was awarded on May 24, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of May 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $45,461.57 contract was awarded on July 16, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a completion date of July 17, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $30,156.28, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 15, 2024 with a completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,987.20, is a delivery order for the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA). The $42,246.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 28, 2022 with an ultimate completion date of October 29, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,656.26 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024, with a completion date of September 6, 2024. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp has been awarded numerous Indefinite Delivery...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,779.46 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $17,743.79, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 15, 2025. The award was made on January 14, 2025, and there was no...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,847.39 firm fixed-price delivery order is for the provision of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $7,956.68, was granted on July 3, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 5, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...